Pretreatment assessment: Computerized axial tomography (CAT) and ultrasonography (US) scans showed (a) a large cyst measuring 10 x 7.75 em beneath the posterior surface of the left lobe of the liver (attenuation value 2HU); (b) a 2.5 em cyst deep in the right lobe of the liver; and (c) a multilocular cyst measuring 7 x 7 em behind the urinary bladder. This cyst contained areas of high (5HU) and low (-6HU) attenuation. Hydatid serology by complement fixation (titre 1/512) and latex agglutination (LA) was positive.
The patient was treated with albendazole 400mg twice daily (15 mg/kg/day) for 28 days. Concentrations of albendazole were monitored by high performance liquid chromatography", Post-treatment assessment: CAT scan showed that the pelvic cyst had increased in size, but the hepatic cysts were unchanged in size and attenuation value. US scan indicated that the subhepatic cyst contained multiple septa. Complement fixation test (1/64), LA, and ELISA were positive. Laparotomy confirmed the scan findings. The two larger cysts were excised, and the viability of contained larvae and germinal layers was investigated using standard histological techniques, light and electron microscopy digestion procedures" and by inoculation into gerbils.
The levels of albendazole sulphoxide fluctuated considerably during the course of treatment of this patient, and no consistent trends were apparent. Serum albendazole trough levels ranged between 2 and 8llg/ml. The cyst level at operation was 0.8I!g/ml.
Direct examination of unfixed material from the large subhepatic cyst showed protoscoleces in various stages of degeneration; none had any flame cell movement. The bulk of the cyst contents was subjected to pepsinisation 5 for 60 min. Most of the larvae and cyst material were digested; some protoscoleces survived this treatment, but there was no indication that any were viable. Histology of the cyst showed intact and apparently viable laminated and germinal layers, but electron microscopy showed that the laminated layer was disintegrated. The tegumental surface of protoscoleces was disrupted, being full of vesicles, spaces and crystals. Occasionally a protoscolex was seen full of crystals and debris. Six gerbils, each injected with 0.5 ml packed germinal layer and protoscoleces, were autopsied at 11 months. None showed any parasite development.
The pelvic cyst proved to be a corpus luteum cyst and there were no signs of recurrence of pelvic hydatid disease. The intrahepatic cyst was not excised.
Discussion
Difficulties in assessing chemotherapy in hydatid infections include failure to obtain proof of parasite viability, both before and after treatment, the unreliability of indirect tests (scans, serology) in determining identity and viability, and ignorance of the natural history ofthe disease. CAT scan, though the most consistent of indirect techniques, may by itself not be reliable in assessing the effects of chemotherapy. In this patient albendazole did not cause radiological reduction in size or change in attenuation value olthe cyst, but the parasite was not viable after 28 days of treatment. Thus, it seems likely that albendazole destroyed the parasite. In assessing the effect of chemotherapy on hydatid disease, we recom-mend that direct evidence of parasite viability be sought using the procedures described above, including electron microscopy in addition to routine histological examination. Naproxen sodium (Naprosyn, Synflex) is a widely prescribed non-steroidal anti-Inflammatory analgesic. We describe a case of pulmonary infiltrate with eosinophilia associated with its use.
Case report
A 45-year-old man who had suffered from ankylosing spondylitis for 17 years was referred with a two-week history of unproductive cough. frontal headaches, generalized malaise and night sweats. Nineteen days before the onset of these symptoms he had begun regular therapy with naproxen sodium. Prior to this he had been taking phenylbutazone for 15 years and subsequently piroxicam for 18 months. He was on no other medication and had no previous history of allergic reactions. On physical examination he was apyrexial with normal pulse and blood pressure. There was a grade I aortic diastolic murmur on auscultation ofthe heart. There were no abnormal signs in the respiratory system and, apart from the features of mild ankylosing spondylitis, examination was normal. A chest radiograph (Figure 1) showed bilateral, upper zone, predominantly peripheral infiltrates. The initial clinical differential diagnosis at this stage included both pleuropulmonary fibrosis secondary to ankylosing spondylitis and pulmonary tuberculosis. On admission for further investigation, the leukocyte count was 6.9 x 10 9/1, 50% polymorphonuclear leukoc~tes, 32% lymphocytes, 3% monocytes, 1% basophils and 15% eosinophile. The ESR was elevated at BO mm/h. The haemoglobin was 13.1 g/dl and the platelet count 526 x 10 9 /1. The blood urea, serum electrolytes, calcium and phosphate and the liver function tests were all normal. Stools were negative for ova and parasites.
As no sputum was available, bronchoalveolar lavage (BAL) was performed using the apical segments of the right upper lobe and medial segment of the right middle lobe. Buffered prewarmed normal saline (lBO ml, pH 7.4)was instilled into each segment and recovered by gentle suction into siliconized glass containers. Large numbers of eosinophils were recovered from both segments: B% of 6 x 10 6 cells from the right upper lobe and 27% of 15 x 10 6 cells from the right middle lobe. In 10 control subjects undergoing bronchoscopy for routine diagnostic purposes, BAL was performed in the medial segment ofthe right middle lobe which was radiologically and bronchoscopically normal in all cases. The mean cell recovery in these subjects was 12±3.1 (s.e.) x 10 6 cells, 0.6±0.lB% (mean-r s.e.) eosinophils. Aerobic and anaerobic cultures, mycobacterial and fungal smears and cultures were all negative.
A diagnosis of pulmonary eosinophilia due to naproxen was made and naproxen therapy discontinued. The patient's symptoms resolved completely over the next 2 weeks. A chest radiograph 4 weeks later ( Figure 2 ) showed complete resolution of the infiltrates and the ESR had by then fallen to 4mm/h. The white cell count was 7.4 x 10 9 /1 with 5% eosinophils.
Discussion
We believe that this case demonstrates a pulmonary hypersensitivity reaction to naproxen sodium. The time interval between the start of therapy and the onset of symptoms is similar to the 4 previously reported cases1.2 and the presentation with fever, malaise and pulmonary infiltrates identical. Our patient demonstrated the classical radiological appearance of drug-related pulmonary infiltrates with patchy and predominantly peripheral infiltration".
Pulmonary eosinophilia has been reported as a result of therapy with phenylbutazone" but this drug is unlikely to have been the cause in our patient, who tolerated it for more than 15 years without ill effect. Similarly the length of piroxicam therapy, with the onset of eosinophilia occurring 19 days after its cessation, makes it an unlikely candidate in this case. However, the onset of pulmonary and peripheral blood eosinophilia 14 days after naproxen was started, and its prompt resolution on withdrawal of this drug, strongly suggest a causal involvement. In view of the widespread use of naproxen sodium in clinical practice, physicians should be alerted to the possibility of such hypersensitivity reactions.
The diagnosis of eosinophilic pulmonary infiltrates was made by lung biopsy in the previously described cases of naproxen hypersensitivity'v', In the absence of sputum, bronchoalveolar lavage provides sufficient diagnostic information to enable pulmonary eosinophilia to be differentiated from other causes of pulmonary infiltration, and avoids the risks associated with lung biopsy.
